Emergent BioSolutions, Inc. (EBS)
11.91
+0.01
(+0.08%)
USD |
NYSE |
Dec 08, 16:00
11.91
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Market Cap: 625.51M for Dec. 8, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 212.26B |
| SIGA Technologies, Inc. | 439.69M |
| Tonix Pharmaceuticals Holding Corp. | 146.70M |
| GeoVax Labs, Inc. | 12.23M |
| Black Diamond Therapeutics, Inc. | 156.40M |
Market Cap Related Metrics
| PE Ratio | 9.204 |
| PS Ratio | 0.8386 |
| Price to Book Value | 1.074 |
| Price to Free Cash Flow | 472.57 |
| Price | 11.91 |
| Earnings Yield | 10.86% |
| Operating PE Ratio | 5.703 |
| Normalized PE Ratio | 9.434 |